This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2018
Title: Scott D Olsen: Innovator in Hemoglobin Research
Introduction
Scott D Olsen is a notable inventor based in La Jolla, California. He has made significant contributions to the field of medical research, particularly in the development of innovative hemoglobin-based therapies. His work focuses on enhancing oxygen delivery to tissues, which is crucial for treating various diseases and conditions.
Latest Patents
Scott D Olsen holds 1 patent for his invention titled "Diaspirin crosslinked pegylated hemoglobin." This patent describes PEGylated diaspirin-crosslinked hemoglobin conjugates that exhibit high oxygen affinity. These conjugates also possess enhanced nitrite reductase activity, allowing them to deliver oxygen, carbon monoxide, nitric oxide, or mixtures thereof to tissues effectively.
Career Highlights
Throughout his career, Scott has worked with various organizations, contributing his expertise to advance medical technologies. His innovative approach has led to breakthroughs in the understanding and application of hemoglobin in therapeutic settings.
Collaborations
Scott has collaborated with notable professionals in his field, including Ashok Malavalli and Kim D Vandegriff. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Scott D Olsen's work in hemoglobin research exemplifies the impact of innovation in medicine. His contributions continue to pave the way for new treatments that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile